Cargando…

Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis

BACKGROUND: This review aims to evaluate the supportive effects of frequently used traditional Chinese medicine (TCM) for the treatment of coronavirus disease 2019 (COVID-19). METHODS: Five databases were searched through July 7, 2020. Randomized controlled trials investigating the efficacy of TCM f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Jiang, Yongqing, Yue, Bei, Luan, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322509/
https://www.ncbi.nlm.nih.gov/pubmed/34397691
http://dx.doi.org/10.1097/MD.0000000000026641
_version_ 1783731064126046208
author Li, Feng
Jiang, Yongqing
Yue, Bei
Luan, Lili
author_facet Li, Feng
Jiang, Yongqing
Yue, Bei
Luan, Lili
author_sort Li, Feng
collection PubMed
description BACKGROUND: This review aims to evaluate the supportive effects of frequently used traditional Chinese medicine (TCM) for the treatment of coronavirus disease 2019 (COVID-19). METHODS: Five databases were searched through July 7, 2020. Randomized controlled trials investigating the efficacy of TCM for use in the treatment of COVID-19 were included. Newcastle–Ottawa Scale (NOS) and modified Jadad score were used for the evaluation of the methodological quality of the included studies. Weighted mean difference, odds ratio (OR), and 95% confidence interval (95% CI) were calculated for pooling out results. Data were extracted for conducting a meta-analysis using STATA version 12.0. RESULTS: Eight studies with a total of 750 patients were included in this meta-analysis. All included trial groups involved treatment with TCM and Western medicine, while the control groups were treated only with Western medicine. The intervention therapy significantly improved the overall effective rate (n = 346, OR = 2.5, 95% CIs = 1.46–4.29), fever symptom disappearance rate (n = 436; OR = 3.6; 95% CIs = 2.13–6.08), fatigue symptom disappearance rate (n = 436; OR = 3.04; 95% CIs = 1.76–5.26), cough symptom disappearance rate (n = 436; OR = 2.91; 95% CIs = 1.36–6.19), and sputum production reduction (n = 436; OR = 5.51; 95% CIs = 1.94–15.64). Based on the Newcastle–Ottawa Scale assessment, 6 studies received a score of 4, and 1 study achieved a score of 5. One study was assessed using the modified Jadad score, achieving a score of 6. CONCLUSIONS: The integration of TCM with Western medicine has significantly improved the treatment for COVID-19 patients compared to Western medicine treatment alone. Combined therapy using TCM and Western medicine revealed the potential adjunctive role of TCM in treating COVID-19. However, high-quality clinical studies are still required to further evaluate the efficacy and safety of TCM in the treatment of COVID-19.
format Online
Article
Text
id pubmed-8322509
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-83225092021-08-02 Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis Li, Feng Jiang, Yongqing Yue, Bei Luan, Lili Medicine (Baltimore) 6600 BACKGROUND: This review aims to evaluate the supportive effects of frequently used traditional Chinese medicine (TCM) for the treatment of coronavirus disease 2019 (COVID-19). METHODS: Five databases were searched through July 7, 2020. Randomized controlled trials investigating the efficacy of TCM for use in the treatment of COVID-19 were included. Newcastle–Ottawa Scale (NOS) and modified Jadad score were used for the evaluation of the methodological quality of the included studies. Weighted mean difference, odds ratio (OR), and 95% confidence interval (95% CI) were calculated for pooling out results. Data were extracted for conducting a meta-analysis using STATA version 12.0. RESULTS: Eight studies with a total of 750 patients were included in this meta-analysis. All included trial groups involved treatment with TCM and Western medicine, while the control groups were treated only with Western medicine. The intervention therapy significantly improved the overall effective rate (n = 346, OR = 2.5, 95% CIs = 1.46–4.29), fever symptom disappearance rate (n = 436; OR = 3.6; 95% CIs = 2.13–6.08), fatigue symptom disappearance rate (n = 436; OR = 3.04; 95% CIs = 1.76–5.26), cough symptom disappearance rate (n = 436; OR = 2.91; 95% CIs = 1.36–6.19), and sputum production reduction (n = 436; OR = 5.51; 95% CIs = 1.94–15.64). Based on the Newcastle–Ottawa Scale assessment, 6 studies received a score of 4, and 1 study achieved a score of 5. One study was assessed using the modified Jadad score, achieving a score of 6. CONCLUSIONS: The integration of TCM with Western medicine has significantly improved the treatment for COVID-19 patients compared to Western medicine treatment alone. Combined therapy using TCM and Western medicine revealed the potential adjunctive role of TCM in treating COVID-19. However, high-quality clinical studies are still required to further evaluate the efficacy and safety of TCM in the treatment of COVID-19. Lippincott Williams & Wilkins 2021-07-30 /pmc/articles/PMC8322509/ /pubmed/34397691 http://dx.doi.org/10.1097/MD.0000000000026641 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle 6600
Li, Feng
Jiang, Yongqing
Yue, Bei
Luan, Lili
Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis
title Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis
title_full Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis
title_fullStr Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis
title_full_unstemmed Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis
title_short Use of traditional Chinese medicine as an adjunctive treatment for COVID-19: A systematic review and meta-analysis
title_sort use of traditional chinese medicine as an adjunctive treatment for covid-19: a systematic review and meta-analysis
topic 6600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322509/
https://www.ncbi.nlm.nih.gov/pubmed/34397691
http://dx.doi.org/10.1097/MD.0000000000026641
work_keys_str_mv AT lifeng useoftraditionalchinesemedicineasanadjunctivetreatmentforcovid19asystematicreviewandmetaanalysis
AT jiangyongqing useoftraditionalchinesemedicineasanadjunctivetreatmentforcovid19asystematicreviewandmetaanalysis
AT yuebei useoftraditionalchinesemedicineasanadjunctivetreatmentforcovid19asystematicreviewandmetaanalysis
AT luanlili useoftraditionalchinesemedicineasanadjunctivetreatmentforcovid19asystematicreviewandmetaanalysis